| Title: |
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial |
| Authors: |
Yan, Kexiang, Li, Fuqiu, Bi, Xiaodong, Han, Ling, Zhang, Zhenghua, Chen, Rixin, Li, Yuye, Zhang, Litao, Wang, Xiaohua, Li, Linfeng, Lu, Jianyun, Xu, Ai'e, Yang, Sen, Lu, Yan, Sun, Jianfang, Li, Zhiming, Zhu, Xiaohong, Jiang, Meiying, Zhang, Siping, Wang, Wenqing, Li, Yanling, Meng, Zudong, Li, Hongyi, Mou, Kuanhou, Han, Xiuping, Li, Shanshan, Chen, Aijun, Li, Xin, Liu, Donghua, Zhang, Chunlei, Ji, Chao, Wang, Yu, Cheng, Hao, Cui, Xiaojing, Yao, Xiaoyan, Bai, Xiaoyan, Dong, Guangchao, Xu, Jinhua |
| Source: |
In Journal of the American Academy of Dermatology January 2025 92(1):92-99 |
| Database: |
ScienceDirect |
